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Purpose: To evaluate the ethanol extracts of the flowers, leaves, and stems of Centaurea tchihatcheffii 
Fischer & C.A. Meyer (Asteraceae) for their anti-inflammatory and analgesic activities in male Swiss 
albino mice.  
Methods: For the evaluation of anti-inflammatory activity, hind paw oedema was induced in the mice 
with carrageenan and prostaglandin-E2 (PGE2
) and the mice received either 100 and 200 mg/kg body 
weight doses of the flower extract or 200 mg/kg body weight dose of the leaf and stem extracts. 
Furthermore, ear oedema was induced in other groups of mice with 12-O-tetradecanoyl-13-acetate 
(TPA) and then administered with 0.5 mg/ear dose of the extract of either of the three plant parts. In 
order to evaluate analgesic activity, p-benzoquinone-induced abdominal constriction test was used with 
100, 200 and 400 mg/kg body weight doses of the flower or  200mg/kg body weight dose of the leaf and 
stem extracts administered. Indomethacin and acetylsalicylic acid were the reference drugs for anti-
inflamatory and analgesic evaluations, respectively. Phytochemical screening of the flower extract was 
carried out by thin layer chromatography (TLC). 
Results: The results of evaluation of the anti-inflammatory activities induced by carrageenan and PGE2 
showed that the flower extract diminished cyclo-oxygenase activitiy at the 200 mg/kg dose to the same 
level as the reference drug, indomethacin. However, no anti-inflamatory activity was seen in the TPA-
induced ear oedema model. The extracts from all three parts of the plant showed analgesia in p-
benzoquinone-induced abdominal constriction test. TLC analysis of the flower extract indicated the 
presence of sesquiterpen lactones, which may have been responsible for the analgesic activity. 
Conclusion: Our results support the use of C. tchihatcheffii in traditional medicine in Turkey for their 
anti-inflammatory and analgesic properties.  
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INTRODUCTION 
 
The Mediteranean region is highly rich in 
Centaurea (Asteraceae) species. Although, 
more than 700 species are found in the 
region, only about 178 of them grow in 
Turkey1. Besides their attractive flowers, 
many of the Centaurea genuses have 
significant applications in traditional medicine. 
For instance, the dried flowers of Centaurea 
cyanus L. are used as a 5% infusion to ease 
the symptoms of diarrhoea, as well as to gain 
energy, increase appetite, and relieve chest 
tightness2-3. Centaurea behen L. is used for 
alleviating stomach problems and initiating 
menstruation4 while Centaurea calcitrapa L. 
is used as a 2-6% infusion for the relief of 
fever and Centaurea iberica Trev. ex Spreng 
for relieving abdominal pains and as a 
remedy for insect and snake bites4. Also, 
most of the Centaurea species have been 
used individually or in combination with some 
plants for the folkloric treatment of diabetes, 
rheumatism and inflammation5-6. In addition 
to these traditional uses, the species have 
also found use for their choleretic, digestive,, 
diuretic, astringent, hypotensive, antipyretic, 
cytotoxic, and antibacterial effects7-10.  
 
In this study, the anti-inflammatory and 
analgesic properties of C. tchihatcheffii 
Fischer & C.A. Meyer have been evaluated 
using rodent models.  
 
MATERIALS AND METHODS 
 
Plant material and preparation of extracts  
 
C. tchihatcheffii plant samples were collected 
from the Gölbasi district of Ankara during the 
month of May, 2007. The plant was 
authenticated by Prof. Dr. Mecit Vural of the 
Department of Biology, Faculty of Art and 
Science, Gazi University, Ankara, Turkey. A 
specimen of the original collection was 
placed in the herbarium of the Faculty of 
Pharmacy, Gazi University, Ankara, Turkey 
(Herbarium no. 2592). 
 
The plant materials, comprising of leaves, 
flowers and stems were air-dried at room 
temperature and powdered by using a pestle 
and mortar. Thereafter, 10 g each of the 
leaves, flowers, and stems of C. tchihatcheffii 
was extracted separately with 3 x 200 ml 
80% ethanol (EtOH) at room temperature 
overnight. In each case, the pooled extract 
was evaporated to dryness in vacuo using a 
rotary evaporator at 40 ºC to give a yield of 
38.5 % (flowers), 39.2 % (leaves) and 35.0 % 
(stem). 
 
Drugs and chemicals 
 
Carrageenan (Sigma, St. Louis, Missouri, 
USA), PGE2 (Fluka Chemie AG), 12-O-
tetradecanoyl-13-acetate (TPA) (Sigma-
Aldrich, St.Louis, USA), p-benzoquinone 
(Merck), indomethacin (Bayer AG), 
acetylsalicylic acid (Bayer AG), sodium 
carboxymethylcellulose (Aldrich Steinheim, 
Germany), absolute ethanol (Merck) were 
used as drugs and/or chemicals.  
 
The plant extracts were suspended in a 
mixture of distilled H2O and 0.5% sodium 
carboxymethyl cellulose (CMC) and given to 
the test animals by mouth. The control group 
received the same treatment as the test 
groups except that the drug was replaced 
with an appropriate volume of vehicle. 
Indomethacin (10 mg/kg and 0.5 mg/ear) and 
acetylsalicylic acid (ASA; 200 mg/kg) in 0.5% 




Male Swiss albino mice (20-25 g) were 
purchased from the animal breeding 
laboratories of Refik Saydam Central Institute 
of Health, Ankara, Turkey. The animals were 
left for two days, to acclimatize to ambient 
conditions, maintained on standard pellet diet 
and given water ad libitum. The food was 
withdrawn on the day before the experiment; 
however, they were allowed free access to 
water. Throughout the experiments, the 
animals were handled according to the 
prescribed ethical guidelines of Gazi 
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University Ethical Council Project Number: 
G.Ü.ET-05.004 for the care of laboratory 
animals. 
 
In preliminary experiments, 200mg/kg dose 
extract of either the flowers, leaves or stems 
were tested on the animals. At this dose, the 
leaf and stem extracts were not effective 
except for the flower extract. Therefore, a 
dose - response was established by 





Carrageenan-induced hind paw oedema 
model 
 
Carrageenan-induced hind paw oedema 
model was used for the determination of anti-
inflammatory activity11. Six animals were 
used for each extract dose, as well as the 
control and reference groups. For flower 
extract,, 100 and 200 mg/kg doses were 
administered while for the stem and leaf 
extract, only 200 mg/kg dose was given one 
hour after oral administration of the 
extract/drug or vehicle, the subplantar tissue 
of right hind paw of each mouse was injected 
(Hamilton® microsyringe) with 25 µl of 20 
mg/ml of freshly prepared carrageenan in 
physiological saline (0.9% NaCl). For control 
purposes, 25 µl of saline was injected into 
subplantar tissue of left hind paw. Thereafter, 
paw edema was measured at 1.5 h interval 
for 6 h. The difference of thickness in footpad 
was measured with calipers (Ozaki Co., 
Tokyo, Japan). Indomethacin (10 mg/kg) was 
used as the reference drug.  
 
PGE2-induced hind paw oedema model 
 
PGE2-induced hind paw edema model was 
also used for the determination of anti-
inflammatory activity following the method 
described by Kasahara et al12. Six animals 
per group were were given either an extract, 
control and reference drug (indomethacin, 10 
mg/kg). The extract dose was 200 mg/kg for 
each of the plant extract. One hour after oral 
administration of an extract, drug or vehicle 
(control), each mouse received 5 µl of freshly 
prepared suspension of PGE2 (1 mg/ml) in 
Tyrode’s solution by injection into the 
subplantar tissue of the right hind paw except 
that for control, 5 µl of Tyrode’s solution was 
injected into the left hind paw. Thereafter, 
paw edema was measured at 15 min interval 
for 75 min. The difference in the thickness of 
the footpad was measured as earlier 
described.  
 
TPA-induced mouse ear oedema  
 
Each mouse received 20 µl of 125 µg/ml of 
TPA dissolved in 70% EtOH13. Six animals 
were used for each group, namely, each of 
the extracts, control and reference groups. 
For the extracts and reference drug, 0.5 
mg/ear dose was applied by a pipette to both 
anterior and posterior surfaces of the right 
ear. The same volume of solvent (70% EtOH) 
was applied to the left ear which served as 
control. Anti-inflammatory activity was 
determined by two different methods. First, 
the thickness of each ear was measured 4 h 
after induction of inflammation with calipers 
and the level of oedema was expressed as 
the difference in thickness between the right 
and left ears. Inhibition (%) was expressed as 
a reduction in thickness with respect to the 
control. In the second method, the animals 
were killed under deep ether anesthesia 4 h 
after drug/extract administration. Discs of 6 
mm diameter were removed from each ear 
and weighed. The swelling was estimated as 
the difference in weight between the discs cut 
from the right and left ears, which was 




p-Benzoquinone - induced abdominal 
constriction test14 was performed on mice in 
order to determine analgesic activity. Six 
animals were used for each of the following 
groups: each extract, control (distilled water) 
and reference drug (ASA, 200 mg/kg). For 
the extracts, the doses administered were 
100, 200, 400 mg/kg doses (flower) and 200 
Koca  et al 
Trop J Pharm Res, June 2009; 8 (3):  196 
mg/kg (leaf and stem). One hour after oral 
administration of an extract, drug, or 
reference drug, the mice were given 
intraperitoneal injections of 0.1 ml/10 g body 
weight of 2.5% w/v of solution of p-
benzoquinone (PBQ) in distilled water. The 
mice were then observed individually 5 min 
after PBQ injection for the number of 
abdominal contractions (writhing movements) 
for a period of 15 min.  
 
The mice were killed under deep ether 
anesthesia and the stomach of each mouse 
was removed, opened through the greater 
curvature and examined under a dissecting 
microscope for lesions or bleedings. 
 
Statistical analysis of data 
 
Data obtained from animal experiments were 
expressed as mean ± S.E.M (standard error 
of the mean). Statistical differences between 
the treated and the control groups were 
evaluated by ANOVA and Students-Newman-





Table 1 shows the dose - response data of 
the extracts with regard to p-benzoquinone-
induced abdominal constriction). All the 
animals died within 2 h following the 
administration of 400 mg/kg dose of the 
flower extract but no effect was observed at 
100 mg/kg dose. Consequently, 200 mg/kg 
dose was selected for further experiments. 
Although the leaf and stem extracts did not 
exert any meaningful analgesic effect, the 
flower extract (200 mg/kg dose) significantly 
inhibited (35.3%) abdominal constriction in 
the mice. Furthermore, no ulceration was 
observed in stomach of the animals following 
the administration of the flower extract. 
 
Flower extracts displayed significant inhibition 
(24.8-34.0%) at dose of 200 mg/kg also in 
carrageenan-induced hind paw oedema 
compared to the other extracts (Table 2).  In 
this regard the inhibitory effect of the flower 
extract (34%) was close to that of 
indomethacin (38.7%) after 270 min. 
 
The results of the anti-inflammatory effect of 
the extracts on hind-paw oedema induced by 
prostaglandin E2 are indicated in Table 3. 
This time measurements were kept between 
0-60 min. with 15 min intervals. The extract of 
flowers considerably inhibited (23.2 - 27.2 % 
inhibition) hind-paw oedema while the leaf 
and stem extracts did not demonstrate a 
notable activity (Table 3). Maximum inhibition 
(27.2 %) by the flower extract was observed 
after 45 min which decreased thereafter. The 
reference drug (indomethacin) presented a 
similar trend, peak at 38% inhibition after 45 
min. 
 
As shown in Table 4, while indomethacin 
exhibited 74.5% inhibition on swelling 
thickness and 38.9% inhibition on weight 
edema, the flower extract displayed only 20.6 
and 12% inhibition, respectively, thus 
indicating that the plant parts did not show 
remarkable anti-inflammatory activity in the 




Subcutaneous injection of carrageenan into 
the rat paw produces plasma extravasation 
and inflammation that are characterized by 
elevated tissue water and plasma protein 
exudation with neutrophil extravasation, in 
addition to increased metabolism of 
arachidonic acid by both cyclo-oxygenase 
and lipoxygenase enzyme pathways15-16. 
There are biphasic effects in carrageenan-
induced oedema. The first phase begins 
immediately after injection and diminishes in 
1 h. The second phase begins in an hour and 
remains through 3 h 17. It is suggested that 
the early hyperemia of carrageenan-induced 
oedema results from the release of histamine 
and serotonin18. On the other hand, the 
delayed phase of carrageenan-induced 
oedema results mainly from the potentiating 
effect of prostaglandins on mediator release, 
particularly  bradykinin.  Hydrocortisone  and  
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Table 1: Effect of the extracts of various parts of C. tchihatcheffii on p-benzoquinone-induced 









Control - 42.2 ± 4.8  0/6 
Leaf 200 44.3 ± 3.3 - 2/6 
 100 39.3 ± 2.7 6.9 0/6 
Flower 200     27.3 ± 2.4** 35.3 0/6 
 400 45.2 ± 1.4 ---- 
a 
Stem 200 52.3 ± 1.9 ---- 1/6 
ASA 200      19.3 ± 2.4*** 54.3 4/6 
 
    *:p<0.05. **:p<0.01. ***:p<0.001 (compared to control, n = 6) 
     a The animals died in 2 h; therefore, ratio of ulceration could not be determined 
       
Table 2: Effect of the extracts of different parts of C. tchihatcheffii on carrageenan-induced paw 
edema in mice 
 
90 min 180 min 270 min 360 min Extract/ 
Drug 
Dose 


















Control  43.2 ± 3.9 0 55.2 ± 3.5 - 60.5 ± 2.3 - 64.3 ± 4.5  
Leaf 200 40.8 ± 3.7 5.6 49.8 ± 2.3 9.8 54.8 ± 3.1 9.4 60.2 ± 3.1   6.4 
Flower 100 41.7 ± 4.3 3.5 51.6 ± 4.9 6.5 59.1 ± 3.6 2.3 61.2 ± 4.7 4.8 
 200 34.7 ± 3.2 19.7 41.5 ± 2.1 24.8* 39.9 ± 4.1 34.0** 44.2 ± 2.2   31.3** 
Stem 200 40.5 ± 4.5 6.3 51.2 ± 3.2 7.2 58.2 ± 4.9 3.8 55.3 ± 3.4 13.9 
Indomethacin 10 34.0 ± 3.1 21.3 35.3 ± 1.9  36.1** 37.1 ± 2.1  38.7*** 39.9 ± 1.8 37.9*** 
Swell. thick.= Swelling thickness (x10-2 mm); SEM = standard error mean; Inh. = Inhibiton.  
*:p<0.05. **:p<0.01. ***:p<0.001 (compared to control, n = 6) 
 




Swell. thick.= Swelling thickness (x10-2 mm); SEM = standard error mean, Inh. = Inhibition. 
*:p<0.05. **:p<0.01. ***:p<0.001 (compared to control, n = 6);  

































Control  1.5±0.9 - 11.4±1.5 - 20.3±1.9 - 27.6±2.3 - 25.9±2.5 - 19.7±1.6 - 
Leaf 200 1.6±0.7 - 15.8±1.1 - 24.7±1.4 - 29.5±1.7 - 31.7±2.4 - 27.6±1.8 - 
Flower 200 1.5±0.8 - 13.1±1.3 - 15.6±1.1 23.2* 20.1±1.4 27.2* 20.1±1.2 19.7 17.6±1.4 10.7 
Stem 200 1.7±0.9 - 10.2±1.4 10.5 19.7±1.6 2.9 29.2±2.3 - 27.6±2.7 - 20.3±2.1 - 
Indome- 
thacin  
10 1.5±0.6 - 9.8±1.3 14.0 13.9±1.4 31.5** 17.1±1.3 38.0*** 20.4±1.1 21.2* 16.8±1.5 14.7 
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(µm) ± S.E.M 
Inhibition % 
Weight edema 
(mg) ± S.E.M 
Inhibition % 
Control - 211.9 ± 40.7  31.6 ± 7.3  
Folia 0.5 199.4 ± 28.9 5.9 35.1 ± 6.5 --- 
Flowers 0.5 168.2 ± 31.5 20.6 27.8 ± 5.1 12.0 
Stem 0.5 236.7 ± 45.2 --- 37.5 ± 8.3 --- 
Indomethacin 0.5 54.1 ± 23.0 74.5*** 19.3 ± 5.2 38.9*** 
      *:p<0.05.**:p<0.01. ***:p<0.001 ; S.E.M: standard error mean 
 
 
some NSAIDs inhibit strongly the second 
phase of carrageenan-induced oedema19. 
Flowers of C. tchihatcheffii seemed effective 
in both phases of acute inflammation. 
Therefore, C. tchihatcheffii may block 
prostaglandin and/or bradykinin release, and 
histamine and/or serotonin. 
 
Although the TPA model has limited selectivity 
in determining the possible mechanism of 
action, it is appropriate for assessing anti-
inflammatory effects in a first stage trial. It has 
been established that this agent exerts its 
inflammatory effect through protein kinase C 
activation with the subsequent cytosolic 
phospholipase A2 stimulation, AA mobilization, 
and biosynthesis of prostaglandins and 
leukotrienes20.  
 
In contrast with the results obtained in the 
carrageenan-induced hind paw oedema 
model, the flower extract failed to inhibit ear 
oedema. This may be due to the different 
mechanisms of action of the phlogistic agents 
or to the fact that the systemic route of 
administration failed to achieve adequate 
concentration of the compounds at the site of 
inflammation. 
 
In a earlier study, 2-methylpropanoate and 2-
methyl-2-propenoate of 11, 13-dehydro-
melitensin, were isolated from the aerial parts 
of C. chilensis. The mixture of both 
substances exhibited anti-inflammatory 
activity in the carrageenan-induced paw 
edema assay21. A 20 % infusion, administered 
orally at a dose of 4 ml/kg, exhibited a mild 
inflammatory activity on laboratory animals 
while 400 and 600 mg/kg doses of the 
methanol extract with propylene-glycol  as the 
solvent produced 29 and 49% inhibition, 
respectively. Naproxen-sodium (4.3 mg/kg), 
used as a reference, showed 58% inhibitions. 
According to these results, the extracts of C. 
chilensis were at least as effective as other 
synthetic inflammatory compounds due to the 
presence of sesquiterpene lactones (notably 
α-methylene-γ-lactone) but less effective than 
naproxen.  
 
The presence of orally effective anti-
inflammatory sesquiterpene lactones clarifies 
the traditional use of these plants to heal 
inflammatory diseases18. These results are 
valuable since C. chilensis is from the same 
family as C. tchihatcheffii and might contain 
the compounds. Our unpublished 
chromatographic studies on the flower 
extracts of C. tchihatcheffii show that it 
contains sesquiterpene lactones.  
 
Garbacki et al studied the anti-inflammatory 
properties of polysaccharides extracted from 
C. cyanus flower heads22. These 
polysaccharides were found to be primarily 
composed of galacturonic acid, arabinose, 
glucose, rhamnose and galactose. Fractions, 
soluble only in water, as well as those soluble 
in both water and ethanol were effective 
against carrageen-induced oedema; however, 
the fraction, which was insoluble in ethanol, 
was more effective. This fraction showed 69% 
inhibition of carrageen-induced oedema at a 
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dose of 60 mg/kg and 52% inhibition of croton 
oil-induced edema at 800 µg/ear topical 
administration22. 
 
A study has asserted that the anti-
inflammatory effect of the compound, 
centaureidin, is the result of inhibition of the 
activities related to lipoxygenases and cyclo-
oxygenase in the path7. Another study has 
demonstrated the anti-inflammatory effects of 
C. hierapolitana, C. calolepis and C. cadmea 
in vitro. The extracts of these plants exhibited 
strong anti-inflammatory activities by inhibiting 
their effects on the activation of the 
transcription factor, NF-kappa B 23. These 
authors also declared that a good number of 
Centaurea species frequently contain 
sesquiterpene lactone derivatives and 
flavonoid derivatives and thus their activity 





The analgesic and anti-inflammatory activities 
of leaf and stem extracts of C. tchihatcheffii 
were found to be statistically insignificant but 
the flower extract showed these significant 
biological activities without inducing any 
apparent acute toxicity as well as gastric 
damage at a dose of 200 mg/kg body weight. 
This suggests that C. tchihatcheffii may 
reduce the risk of inflammation-related 
diseases and thus supports the folkloric of 
most of the Centaurea species for 
inflammatory conditions. However, further 
studies need to be conducted in order to 
clarify which constituent(s) of the extract is/are 
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